Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes
EuroIntervention · 2024-08 · 20 (16) · 996-1007
DOI: 10.4244/eij-d-23-01049 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift EuroIntervention, 2024-08. Verfasst von Willem Lambertus Wilbert Bor und 8 weiteren Autor:innen. Beteiligte Einrichtung: St. Antonius Hospital, Nieuwegein, the Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation, Acute Coronary Syndrome, Registries, Anticoagulants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Acute coronary syndrome (ACS) is frequently accompanied by newly diagnosed atrial fibrillation (AF). AIMS: We aimed to compare the risk of major adverse cardiovascular events (MACE) in ACS patients presenting with known, newly diagnosed, or no AF. METHODS: In our multicentre, prospective registry study, we included patients with confirmed ACS. Patients are classified as having known, newly diagnosed or no AF. Newly diagnosed AF is subdivided according to the duration of the episode, time of onset, post-coronary artery bypass graft (CABG) or spontaneous occurrence, and treatment with oral anticoagulants (OAC). The primary endpoint is MACE at 1 year. Key secondary endpoints include ischaemic stroke and bleeding complications. RESULTS: Amongst 4,433 patients with confirmed ACS, 3,598 (81.2%) had no AF, 438 (9.9%) had newly diagnosed AF, and 397 (9.0%) had known AF. The rates of OAC treatment at discharge were 53.4% in patients with newly diagnosed AF and 89.2% in patients with known AF. After adjusting for baseline imbalances, only new AF was independently associated with increased rates of MACE, whereas known AF was not (hazard ratio [HR] 1.52, 95% confidence interval [CI]: 1.19-1.90 and HR 0.93, 95% CI: 0.70-1.23). For ACS patients with newly diagnosed AF, episodes lasting >24 hours were associated with a higher risk of MACE compared to episodes 24 hours was associated with worse outcomes than shorter episodes, while post-CABG occurrence of AF showed relatively better outcomes compared to spontaneously occurring AF. Only 53% of new AF patients were discharged on OAC therapy versus 89% with known AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- St. Antonius Hospital, Nieuwegein, the Netherlands.
- Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- CARIM, School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
Zitieren
APA
Bor, W. L. W., Azzahhafi, J., Maio, N. D., van der Sangen, N. M. R., Verburg, A., Rayhi, S., Peper, J., Chan Pin Yin, D. R. P. P., & Ten Berg, J. M. (2024). Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes. EuroIntervention, 20(16), 996-1007. https://doi.org/10.4244/eij-d-23-01049
Vancouver
Bor WLW, Azzahhafi J, Maio ND, van der Sangen NMR, Verburg A, Rayhi S, et al. Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes. EuroIntervention. 2024;20(16):996-1007. doi:10.4244/eij-d-23-01049
BibTeX
@article{Bor2024,
author = {Bor, Willem Lambertus Wilbert and Azzahhafi, Jaouad and Maio, Nino di and van der Sangen, Niels M R and Verburg, Ashley and Rayhi, Senna and Peper, Joyce and Chan Pin Yin, Dean R P P and Ten Berg, Jurrien M},
title = {Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes},
journal = {EuroIntervention},
year = {2024},
volume = {20},
number = {16},
pages = {996--1007},
doi = {10.4244/eij-d-23-01049}
}
EUVIMED